CVS Health (CVS) P/E ratio
CVS Health (CVS) trades at 10.0× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 57.1×. That is 365.5% higher than the 12.3× of fiscal 2024. Figures as of 18 Nov 2026, 08:40 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/E ratio today
- 10.0×
- P/E ratio, fiscal 2025
- 57.1×
- Change on fiscal 2024
- +365.5%
- Highest on record
- 57.1×fiscal 2025
- Lowest on record
- 11.3×fiscal 2017
- Fiscal years on record
- 182007–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
CVS Health P/E ratio, in more detail
Today's figure is 82.5% below the fiscal 2025 year-end.
Across the 18 fiscal year-ends on record (2007–2025), the highest was 57.1× in fiscal 2025 and the lowest 11.3× in fiscal 2017. Today's P/E ratio is at or below every one of the 18 fiscal year-ends on record; their median is 15.9×.
P/E ratio at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
CVS Health P/E ratio, year by year
| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
|---|---|---|---|---|---|
| Today | 10.0× | — | $85.81 | — | |
| 2025 | 57.1× | 365.5% up | $79.36 | $1.39 | |
| 2024 | 12.3× | 0.5% up | $44.89 | $3.66 | |
| 2023 | 12.2× | 57.3% down | $78.96 | $6.47 | |
| 2022 | 28.6× | 66.8% up | $93.19 | $3.26 | |
| 2021 | 17.1× | 37.0% up | $103.16 | $6.02 | |
| 2020 | 12.5× | 14.5% down | $68.30 | $5.46 | |
| 2019 | 14.6× | — | $74.29 | $5.08 | |
| 2018 | — | — | $65.52 | -$0.57 | |
| 2017 | 11.3× | 30.1% down | $72.50 | $6.44 | |
| 2016 | 16.1× | 23.7% down | $78.91 | $4.90 | |
| 2015 | 21.1× | 13.2% down | $97.77 | $4.63 | |
| 2014 | 24.3× | 27.1% up | $96.31 | $3.96 | |
| 2013 | 19.1× | 19.5% up | $71.57 | $3.74 | |
| 2012 | 16.0× | 0.9% up | $48.35 | $3.02 | |
| 2011 | 15.9× | 13.6% up | $40.78 | $2.57 | |
| 2010 | 14.0× | 10.5% up | $34.77 | $2.49 | |
| 2009 | 12.6× | 4.2% down | $32.21 | $2.55 | |
| 2008 | 13.2× | 36.3% down | $28.74 | $2.18 | |
| 2007 | 20.7× | — | $39.75 | $1.92 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
How to read it
It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.
P/E ratio at health care companies of similar size
| Company | P/E ratio |
|---|---|
| McKesson MCK | 28.2× |
| Sanofi SNY | 23.6× |
| CVS Health CVS | 10.0× |
| HCA Healthcare HCA | 16.6× |
| GSK GSK | 17.2× |
Price over the last twelve months' earnings per share, as the market data feed reports it.
CVS Health, figure by figure
- CVS Health market cap
- CVS Health revenue
- CVS Health earnings
- CVS Health earnings per share (EPS)
- CVS Health P/S ratio
- CVS Health P/B ratio
- CVS Health free cash flow
- CVS Health operating margin
- CVS Health dividend
- CVS Health shares outstanding
- CVS Health total debt
- CVS Health cash on hand
- CVS Health total assets
- CVS Health return on equity (ROE)
- CVS Health return on invested capital (ROIC)
CVS Health (CVS) overview: price, valuation and scorecardAll health care companies by market value
CVS Health P/E ratio: questions and answers
What is CVS Health's P/E ratio?
CVS Health (CVS) trades at 10.0× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 57.1×. That is 365.5% higher than the 12.3× of fiscal 2024.
Is CVS Health's P/E ratio high or low compared with its own history?
Today's P/E ratio is at or below every one of the 18 fiscal year-ends on record; their median is 15.9×.
What are the highest and lowest P/E ratio figures on record for CVS Health?
Across the 18 fiscal year-ends on record (2007–2025), the highest was 57.1× in fiscal 2025 and the lowest 11.3× in fiscal 2017.
How is CVS Health's P/E ratio calculated?
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/E ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “CVS Health (CVS) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CVS/pe-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.